feed,title,long_url,short_url
Investors,Regeneron And Sanofi Snag Their $6 Billion-Potential COPD Approval For Dupixent,https://www.investors.com/news/technology/regeneron-stock-dupixent-copd-treatment-2/,https://da.gd/QHOV
